Medtronic Announces First Clinical Data On Occipital Nerve Stimulation For Chronic Migraine
Jun 30th 2008Drug InformationHeadache / Migraine
Medtronic, Inc. (NYSE: MDT) announced that data from a multicenter, prospective, randomized, singleblinded, Controlled investigational study using its neurostimulation system to stimulate the occipital nerves as a potential approach to treating medically refractory chronic migraines will be presented during a late-breaking session at the annual scientific meeting of the American Headache Society (AHS) tomorrow in Boston.
More: continued here
No Comments »
Leave a Reply
You must be logged in to post a comment.
